Moving beyond hydroxychloroquine: The novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies

Trace M. Jones; Claudia Espitia; Wei Wang; Steffan T. Nawrocki; Jennifer S. Carew

doi:10.1186/s40880-019-0418-0

Moving beyond hydroxychloroquine: The novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies

Trace M. Jones
, Claudia Espitia
, Wei Wang
, Steffan T. Nawrocki
, Jennifer S. Carew

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Article number	72
Journal	Cancer Communications
Volume	39
Issue number	1
DOIs	https://doi.org/10.1186/s40880-019-0418-0
State	Published - Nov 9 2019

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1186/s40880-019-0418-0

Cite this

@article{e894e8e02205492faa565c3012c86bbe,

title = "Moving beyond hydroxychloroquine: The novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies",

author = "Jones, \{Trace M.\} and Claudia Espitia and Wei Wang and Nawrocki, \{Steffan T.\} and Carew, \{Jennifer S.\}",

year = "2019",

month = nov,

day = "9",

doi = "10.1186/s40880-019-0418-0",

language = "English (US)",

volume = "39",

journal = "Cancer Communications",

issn = "1000-467X",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Moving beyond hydroxychloroquine

T2 - The novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies

AU - Jones, Trace M.

AU - Espitia, Claudia

AU - Wang, Wei

AU - Nawrocki, Steffan T.

AU - Carew, Jennifer S.

PY - 2019/11/9

Y1 - 2019/11/9

UR - https://www.scopus.com/pages/publications/85074741664

UR - https://www.scopus.com/pages/publications/85074741664#tab=citedBy

U2 - 10.1186/s40880-019-0418-0

DO - 10.1186/s40880-019-0418-0

M3 - Comment/debate

C2 - 31706349

AN - SCOPUS:85074741664

SN - 1000-467X

VL - 39

JO - Cancer Communications

JF - Cancer Communications

IS - 1

M1 - 72

ER -

Moving beyond hydroxychloroquine: The novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this